Dr Clare Slaney
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
41 Scholarly works
8 Projects
HIGHLIGHTS
2025
Journal article
Optimised modular anti-FLAG CAR T cells for solid tumor therapy
DOI: 10.1002/cti2.700462024
Journal article
Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals
DOI: 10.1002/cti2.700162024
Journal article
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
DOI: 10.1038/s41586-024-07242-12023
Journal article
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells
DOI: 10.1038/s41467-023-37161-02020
Research grants (ARC, NHMRC, MRFF)
Car T Cells and "A Good Beating" for Cancer Therapy
2020
Research grants (other domestic)
Car T Cells and a Good \201cbeating\201d for Breast Cancers
2018
Research Grant
Using Lessons From Toxic Shock Syndrome to Enhance Breast Cancer Immunotherapy
RECENT SCHOLARLY WORKS
2023
Journal article
TSTEM-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models
DOI: 10.1126/scitranslmed.abk19002023
Journal article
Editorial: Combining chemo/radio therapy and immunotherapy for cancers—perfect mix of old and new
DOI: 10.3389/fimmu.2022.11296232021
Journal article
Enhancing adoptive cell transfer with combination braf-mek and cdk4/6 inhibitors in melanoma
DOI: 10.3390/cancers132463422021
Journal article
Cellular networks controlling T cell persistence in adoptive cell therapy
DOI: 10.1038/s41577-021-00539-62021
Journal article
A histone deacetylase inhibitor, panobinostat, enhances chimeric antigen receptor T-cell antitumor effect against pancreatic cancer
DOI: 10.1158/1078-0432.CCR-21-11412021
Journal article
Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies
DOI: 10.1136/jitc-2021-002555
RECENT PROJECTS
2017
Research Grant
Targeting Breast Cancer Using Adoptive Cell Transfer Incorporating Vaccination
2016
Research Grant
Breast Cancer Therapy Using Dual-Specific T Cells